CMT Clinical Trials

Use our clinical trial finder to match and participate in current available trials.


 The Drug Development Pipeline outlines current therapies under development in industry.

Recruiting for a new clinical trial

The purpose of this study is to determine the best way to measure progression of CMT1A over time.  This study is important to prepare for clinical trials.

For more information, please contact:

Beth Wood at University of Rochester:

Alexa Bacha at University of Iowa:

Learn more about current clinical trials

The imperative research for the development of CMT treatments is dependent on the funding from organizations like us.

To support our efforts to accelerate treatments for CMT, please donate today.